^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

fluoxetine

i
Other names: LY-110140, LY 110140
Company:
Generic mfg.
Drug class:
Selective serotonin reuptake inhibitor
11d
Selective serotonin reuptake inhibitor fluoxetine, reduces solid tumor burden and metastasis through activation of host antitumor immune response and modulation of tumor microenvironment. (PubMed, J Pharmacol Exp Ther)
SIGNIFICANCE STATEMENT: Fluoxetine, an US Food and Drug Administration-approved selective serotonin reuptake inhibitor reduces solid tumor (breast and melanoma) load through immune mediated tumor cell death and restore antitumor immunity. It remodels tumor microenvironment, activates T cells, reduces cancer stemness and metastasis via regulation of epithelial mesenchymal transition factors, hypoxia Inducible factor 1α, and β-catenin.
Journal • IO biomarker
|
IFNG (Interferon, gamma) • CTNNB1 (Catenin (cadherin-associated protein), beta 1) • HIF1A (Hypoxia inducible factor 1, alpha subunit) • CASP8 (Caspase 8)
|
fluoxetine
14d
Sanhua essential oil exerts antidepressant effects in breast cancer-related depression by modulating metabolic pathways. (PubMed, Phytomedicine)
SEO exerts antidepressant-like effects in BCRD by modulating hippocampus-centered metabolic and functional networks. Eugenol and 2-phenylethanol were identified as key brain-entry components to function through metabolic pathways. ALOX15 inhibition and CAII improvement were proven to be the main molecular mechanisms. These findings provide mechanistic insights and identify SEO as a promising plant-derived therapeutic candidate for managing cancer-related depression.
Journal
|
FUS (FUS RNA Binding Protein) • ALOX15 (Arachidonate 15-Lipoxygenase)
|
fluoxetine
14d
Fluoxetine on Emotional Experience (FLEX) Study (clinicaltrials.gov)
P=N/A, N=80, Recruiting, University of Oxford
New trial
|
fluoxetine
20d
Xuefu Zhuyu Capsule alleviates depression in post-stroke depression model rats via modulation of the gut microbiota-gut-brain axis. (PubMed, Drug Discov Ther)
Wistar rats were randomly assigned to sham, PSD, three XFZY dose (0.216, 0.432, 0.864 g/kg), and fluoxetine (1.80 mg/kg) groups (n = 12 per group)...Furthermore, after depletion of gut microbiota using antibiotic cocktails, these therapeutic effects of XFZY were abolished. In summary, XFZY may alleviate PSD by modulating the gut microbiota and regulating the gut-brain axis, offering a promising direction for future therapeutic research.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
fluoxetine
1m
Study on the Efficacy and Safety of Esketamine Hydrochloride Nasal Spray Combined with Antidepressants in Rapidly Improving Symptoms in Patients with Depression (ChiCTR2600116233)
P=N/A, N=120, Not yet recruiting, The First Affiliated Hospital of Xi'an Jiaotong University; The First Affiliated Hospital of Xi'an Jiaotong University
New trial
|
fluoxetine
1m
A randomized controlled study on the combination of fasudil hydrochloride and PD1 inhibitors with androgen deprivation therapy in neoadjuvant treatment of prostate cancer (ChiCTR2500112026)
P=N/A, N=83, Not yet recruiting, The Affiliated Zhongda Hospital of Southeast University; The Affiliated Zhongda Hospital of Southeast University
New trial
|
fluoxetine
1m
STAMD: Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD) (clinicaltrials.gov)
P1/2, N=520, Recruiting, First Affiliated Hospital of Chongqing Medical University | Trial primary completion date: Dec 2025 --> Dec 2026
Trial primary completion date
|
fluoxetine • olanzapine
2ms
Acupuncture as a modulator of microglial polarization and pyroptosis in depression: evidence from a chronic unpredictable mild stress rat model. (PubMed, Metab Brain Dis)
Acupuncture alleviates depression-like behaviors in CUMS-induced rats by modulating microglial polarization and inhibiting neuroinflammation-mediated pyroptosis. Our findings provide further evidence supporting acupuncture as a viable strategy for depression treatment.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL10 (Interleukin 10) • IL1B (Interleukin 1, beta) • IL4 (Interleukin 4) • MRC1 (Mannose Receptor C-Type 1) • NLRP3 (NLR Family Pyrin Domain Containing 3) • CASP1 (Caspase 1)
|
fluoxetine
2ms
Hypersensitization of peripheral immune cells from major depressive disorder patients is mildly attenuated by fluoxetine in vitro. (PubMed, Prog Neuropsychopharmacol Biol Psychiatry)
In summary, fluoxetine has highly significant immunoregulatory effects in patients with MDD and not in controls. Unfortunately, these effects only partly attenuate the immune sensitization in MDD.
Preclinical • Journal
|
IFNG (Interferon, gamma) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • CXCL10 (Chemokine (C-X-C motif) ligand 10) • CCL27 (C-C Motif Chemokine Ligand 27)
|
fluoxetine
2ms
Xianglian Pills ameliorate ulcerative colitis combined with depression in mice via histone demethylation (PubMed, Zhongguo Zhong Yao Za Zhi)
Fifty male C57BL/6 mice were randomized into control, model, XLP(2.7, 5.4 mg·g~(-1)), and 5-aminosalicylic acid+fluoxetine groups...Furthermore, XLP lowered the levels of TNF-α, IL-1β, IL-6, and IL-23, down-regulated the transcript levels of IL-6 and IL-23α and the protein level of H3K4me3 while up-regulating the protein level of KDM5B in the cerebral cortical area and the colon tissue, and increased the binding of KDM5B to the IL-6 and IL-23α promoters. XLP may affect H3K4me3 demethylation through KDM5B to reduce the production of inflammatory factors and alleviate the inflammatory response, thus ameliorating UC combined with depression.
Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL23A (Interleukin 23 Subunit Alpha) • IL1B (Interleukin 1, beta) • KDM5B (Lysine Demethylase 5B)
|
fluoxetine
3ms
Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer. (PubMed, Cell Metab)
Attenuating peripheral serotonin using fluoxetine-a selective serotonin reuptake inhibitor (SSRI) antidepressant-ablates TAM-derived EV delivering of inositol metabolic enzymes and sensitizes tumors to cisplatin/PARP inhibitor (PARPi). Our study unveils a systemic serotonin-primed metabolic crosstalk within the tumor microenvironment that potentiates chemoresistance, revealing targetable HR repair regulation beyond cancer-cell-autonomous mechanisms.
Journal
|
MRE11A (MRE11 homolog, double strand break repair nuclease)
|
cisplatin • fluoxetine